[ Price : $8.95]
Gilead Sciences reports promising results from its Phase 3 ASCENT-03 trial evaluating Trodelvy (sacituzumab govitecan-hziy) in pat...[ Price : $8.95]
A federal judge extends by two weeks a preliminary injunction halting the Trump administrations plans for further reductions in fo...[ Price : $8.95]
FDA grants an expanded interchangeable designation for Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira. ...[ Price : $8.95]
BD recalls its Esophagogastric Balloon Tamponade Tubes to update the devices instructions for use due to difficulties in removing ...[ Price : $8.95]
FDA approves Liquidias Yutrepia (Treprostinil), a new inhalation powder designed to treat adults with pulmonary arterial hypertens...[ Price : $8.95]
A Friends of Cancer Research online data analysis shows the FDA accelerated approval program is working as designed to speed innov...[ Price : $8.95]
A HuffPost report says a tariff on imported drugs could lead to shortages of medications that patients need.[ Price : $8.95]
FDA approves GSKs Nucala (mepolizumab) as an add-on maintenance treatment for certain adults with chronic obstructive pulmonary di...